scholarly article | Q13442814 |
P356 | DOI | 10.1001/JAMA.2018.11406 |
P698 | PubMed publication ID | 30167705 |
P50 | author | Henry R. Kranzler | Q67465892 |
P2093 | author name string | Michael Soyka | |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | alcohol abuse | Q7331102 |
P1104 | number of pages | 10 | |
P304 | page(s) | 815-824 | |
P577 | publication date | 2018-08-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review | |
P478 | volume | 320 |
Q64058138 | Adding an orange to the banana bag: vitamin C deficiency is common in alcohol use disorders |
Q90450428 | Advances in the science and treatment of alcohol use disorder |
Q93068492 | Alcohol use disorders |
Q93064374 | Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders |
Q90107347 | Case Study: Naltrexone for the Treatment of Nitrous Oxide Use |
Q97556121 | Compulsive alcohol consumption is regulated by dorsal striatum fast-spiking interneurons |
Q64230853 | Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation |
Q90929841 | Educational attainment impacts drinking behaviors and risk for alcohol dependence: results from a two-sample Mendelian randomization study with ~780,000 participants |
Q99709219 | Effects of Paternal Preconception Vapor Alcohol Exposure Paradigms on Behavioral Responses in Offspring |
Q93003233 | Epidemiology of Alcohol Use and Alcoholic Liver Disease |
Q92814833 | Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption |
Q98226106 | Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review |
Q97540059 | Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta-analysis |
Q92169542 | HIV and alcohol use disorder: we cannot ignore the elephant in the room |
Q92862556 | Mood Disorders and Severity of Addiction in Alcohol-Dependent Patients Could Be Mediated by Sex Differences |
Q89905655 | Pharmacotherapeutic management of co-morbid alcohol and opioid use |
Q64078580 | Predisposition to Alcohol Drinking and Alcohol Consumption Alter Expression of Calcitonin Gene-Related Peptide, Neuropeptide Y, and Microglia in Bed Nucleus of Stria Terminalis in a Subnucleus-Specific Manner |
Q90828795 | Prevention, screening, and treatment for heavy drinking and alcohol use disorder |
Q90828804 | Psychiatric comorbidities in alcohol use disorder |
Q90737471 | Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder |
Q89739673 | Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies |
Q89964622 | Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder |
Q92069642 | Understanding Addiction Using Animal Models |
Search more.